Bioanalytical Systems Inc (BASI): Connie Leigh Dougherty , VP, Business Development of Bioanalytical Systems Inc purchased 1,655 shares on May 19, 2016. The Insider buying transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.92 per share for a total value of $1,522.60 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 16, 2015, Philip A Downing (VP, Preclinical Srvcs.) purchased 3,000 shares at $1.73 per share price.On Aug 25, 2015, Connie Leigh Dougherty (VP, Business Development) purchased 6,900 shares at $1.42 per share price.Also, On Mar 3, 2015, Jacqueline M Lemke (CEO) purchased 10,000 shares at $2.04 per share price.
Bioanalytical Systems Inc. is an international contract research organization providing drug discovery and development services and analytical instruments. The Company’s clients and partners include pharmaceutical biotechnology academic and government organizations. The Company derives its revenues from sales of its research services and drug development tools. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and biomolecule drug candidates. The Company’s principal clients are scientists engaged in analytical chemistry drug safety evaluation clinical trials drug metabolism studies pharmacokinetics and basic research from small start-up biotechnology companies to many of the global pharmaceutical companies. The Company operates in two business segments: contract research services and research products both of which addresses the bioanalytical preclinical and clinical research needs of drug developers.